Skip to main content
Erschienen in: Somnologie 3/2010

01.09.2010 | Original Contribution

Anfängliche Gewichtszunahme bei kontinuierlicher Positivdruck-Therapie wegen obstruktiver Schlafapnoe

Anfängliche Gewichtszunahme bei CPAP-Therapie

verfasst von: R.E. Bourey, MD, FAASM, J.R. Bourey, N. Habbal, A. Balaa

Erschienen in: Somnologie | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Study objectives

Many clinicians believe that continuous positive airway pressure (CPAP) therapy of obstructive sleep apnea (OSA) is associated with a decrease in body mass, but to date, studies generally suggest long-term stability in body mass after 1 year. We have seen body mass increase after 4 weeks of treatment with CPAP in most patients with OSA. In this study, we test the hypothesis that therapy of OSA with CPAP produces a short-term gain in body mass, and look for physiological correlates to suggest an underlying mechanism.

Methods

Retrospective analysis of 218 consecutive patients treated for sleep apnea at a community-based sleep center.

Results

A total of 152 patients met the criteria for study conclusion. After 1 month of CPAP treatment, 119 subjects (78%) gained mass, including 81% of men and 73% of women. As a group, subjects on CPAP gained 1.4±2.5 kg (mean±SD). The Epworth Sleepiness Scale was reduced after 1 month of CPAP therapy. There was no correlation between gain in body mass and measured parameters. A subgroup of 71 patients remained on therapy. They demonstrated a gain in mass at 4 weeks, which did not persist at 6 months.

Conclusions

CPAP treatment of OSA is associated with gain in body mass at 1 month but not 6 months of therapy. The nature of this gain in mass remains unknown. We believe the gain is due to increased vascular volume, and might represent an early marker of physiological benefit of CPAP. This article includes a review of potential mechanisms for early increase in body mass with CPAP.
Literatur
1.
Zurück zum Zitat Traviss KA, Barr SI, Fleming JA, Ryan CF (2002) Lifestyle-related weight gain in obese men with newly diagnosed obstructive sleep apnea. J Am Diet Assoc 102:703–706CrossRefPubMed Traviss KA, Barr SI, Fleming JA, Ryan CF (2002) Lifestyle-related weight gain in obese men with newly diagnosed obstructive sleep apnea. J Am Diet Assoc 102:703–706CrossRefPubMed
2.
Zurück zum Zitat Phillips BG, Hisel TM, Kato M et al (1999) Recent weight gain in patients with newly diagnosed obstructive sleep apnea. J Hypertens 17:1297–1300CrossRefPubMed Phillips BG, Hisel TM, Kato M et al (1999) Recent weight gain in patients with newly diagnosed obstructive sleep apnea. J Hypertens 17:1297–1300CrossRefPubMed
3.
Zurück zum Zitat Pillar G, Shehadeh N (2008) Abdominal fat and sleep apnea: the chicken or the egg? Diabetes Care 31(Suppl 2):S303–S309CrossRefPubMed Pillar G, Shehadeh N (2008) Abdominal fat and sleep apnea: the chicken or the egg? Diabetes Care 31(Suppl 2):S303–S309CrossRefPubMed
4.
Zurück zum Zitat Ip MS, Lam B, Ng MM et al (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670–676CrossRefPubMed Ip MS, Lam B, Ng MM et al (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670–676CrossRefPubMed
5.
Zurück zum Zitat Punjabi NM, Sorkin JD, Katzel LI et al (2002) Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677–682CrossRefPubMed Punjabi NM, Sorkin JD, Katzel LI et al (2002) Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677–682CrossRefPubMed
6.
Zurück zum Zitat Punjabi NM, Shahar E, Redline S et al (2004) Sleep-disordered breathing, glucose intolerance and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 160:521–530CrossRefPubMed Punjabi NM, Shahar E, Redline S et al (2004) Sleep-disordered breathing, glucose intolerance and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 160:521–530CrossRefPubMed
7.
Zurück zum Zitat Harsch IA, Konturek PC, Koebnick C et al (2003) Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 22:251–257CrossRefPubMed Harsch IA, Konturek PC, Koebnick C et al (2003) Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 22:251–257CrossRefPubMed
8.
Zurück zum Zitat Hong S, Dimsdale JE (2003) Physical activity and perception of energy and fatigue in obstructive sleep apnea. Med Sci Sports Exerc 35:1088–1092CrossRefPubMed Hong S, Dimsdale JE (2003) Physical activity and perception of energy and fatigue in obstructive sleep apnea. Med Sci Sports Exerc 35:1088–1092CrossRefPubMed
9.
Zurück zum Zitat Loube DI, Loube AA, Erman MK (1997) Continuous positive airway pressure treatment results in weight loss in obese and overweight patients with obstructive sleep apnea. J Am Diet Assoc 97:896–897CrossRefPubMed Loube DI, Loube AA, Erman MK (1997) Continuous positive airway pressure treatment results in weight loss in obese and overweight patients with obstructive sleep apnea. J Am Diet Assoc 97:896–897CrossRefPubMed
10.
11.
Zurück zum Zitat Engleman HM, Asgari-Jirhandeh N, McLeod AL et al (1996) Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 109:1470–1476CrossRefPubMed Engleman HM, Asgari-Jirhandeh N, McLeod AL et al (1996) Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 109:1470–1476CrossRefPubMed
12.
Zurück zum Zitat Ryan CF, Love LL, Buckley PA (1995) Energy expenditure in obstructive sleep apnea. Sleep 18:180–187PubMed Ryan CF, Love LL, Buckley PA (1995) Energy expenditure in obstructive sleep apnea. Sleep 18:180–187PubMed
13.
Zurück zum Zitat Engleman HM, Gough K, Martin SE et al (1996) Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in “non-dippers”. Sleep 19:378–381PubMed Engleman HM, Gough K, Martin SE et al (1996) Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in “non-dippers”. Sleep 19:378–381PubMed
14.
Zurück zum Zitat Hein H, Kirsten D, Magnussen H (1997) Nehmen Patienten mit obstruktivem Schlafapnoesyndrom unter nCPAP-Therapie ab? Pneumologie 51(Suppl 3):776–778PubMed Hein H, Kirsten D, Magnussen H (1997) Nehmen Patienten mit obstruktivem Schlafapnoesyndrom unter nCPAP-Therapie ab? Pneumologie 51(Suppl 3):776–778PubMed
15.
Zurück zum Zitat Chin K, Shimizu K, Nakamura T et al (1999) Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100:706–712CrossRefPubMed Chin K, Shimizu K, Nakamura T et al (1999) Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100:706–712CrossRefPubMed
16.
Zurück zum Zitat Harsch IA, Schahin SP, Radespiel-Troger M et al (2004) Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169:156–162CrossRefPubMed Harsch IA, Schahin SP, Radespiel-Troger M et al (2004) Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169:156–162CrossRefPubMed
17.
Zurück zum Zitat Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J et al (2006) Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 129:1459–1467CrossRefPubMed Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J et al (2006) Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 129:1459–1467CrossRefPubMed
18.
Zurück zum Zitat Trenell MI, Ward JA, Yee BJ et al (2007) Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. Diabetes Obes Metab 9:679–687CrossRefPubMed Trenell MI, Ward JA, Yee BJ et al (2007) Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. Diabetes Obes Metab 9:679–687CrossRefPubMed
19.
Zurück zum Zitat Pickering TG, Hall JE, Appel LJ et al (2005) Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 45:142–161CrossRefPubMed Pickering TG, Hall JE, Appel LJ et al (2005) Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 45:142–161CrossRefPubMed
20.
Zurück zum Zitat Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540–545PubMed Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540–545PubMed
21.
Zurück zum Zitat Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system of sleep stages in human subjects. Brain Information Service/Brain Research Institute, University of California, Los Angeles Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system of sleep stages in human subjects. Brain Information Service/Brain Research Institute, University of California, Los Angeles
22.
Zurück zum Zitat Stenlof K, Grunstein R, Hedner J, Sjostrom L (1996) Energy expenditure in obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Am J Physiol 271:E1036–E1043PubMed Stenlof K, Grunstein R, Hedner J, Sjostrom L (1996) Energy expenditure in obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Am J Physiol 271:E1036–E1043PubMed
23.
Zurück zum Zitat Myers MG, Cowley MA, Munzberg H (2008) Mechanisms of leptin action and leptin resistance. Annu Rev Physiol 70:537–556CrossRefPubMed Myers MG, Cowley MA, Munzberg H (2008) Mechanisms of leptin action and leptin resistance. Annu Rev Physiol 70:537–556CrossRefPubMed
24.
Zurück zum Zitat Cooper BG, White JE, Ashworth LA et al (1995) Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 18:172–179PubMed Cooper BG, White JE, Ashworth LA et al (1995) Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 18:172–179PubMed
25.
Zurück zum Zitat Thum T, Fleissner F, Klink I et al (2007) Growth hormone treatment improves markers of systemic nitric oxide bioavailability via insulin-like growth factor-I. J Clin Endocrinol Metab 92:4172–4179CrossRefPubMed Thum T, Fleissner F, Klink I et al (2007) Growth hormone treatment improves markers of systemic nitric oxide bioavailability via insulin-like growth factor-I. J Clin Endocrinol Metab 92:4172–4179CrossRefPubMed
26.
Zurück zum Zitat Phillips BG, Narkiewicz K, Pesek CA et al (1999) Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 17:61–66CrossRefPubMed Phillips BG, Narkiewicz K, Pesek CA et al (1999) Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 17:61–66CrossRefPubMed
27.
Zurück zum Zitat Krieger J, Imbs JL, Schmidt M, Kurtz D (1988) Renal function in patients with obstructive sleep apnea. Effects of nasal continuous positive airway pressure. Arch Intern Med 148:1337–1340CrossRefPubMed Krieger J, Imbs JL, Schmidt M, Kurtz D (1988) Renal function in patients with obstructive sleep apnea. Effects of nasal continuous positive airway pressure. Arch Intern Med 148:1337–1340CrossRefPubMed
28.
Zurück zum Zitat Follenius M, Krieger J, Krauth MO et al (1991) Obstructive sleep apnea treatment: peripheral and central effects on plasma renin activity and aldosterone. Sleep 14:211–217PubMed Follenius M, Krieger J, Krauth MO et al (1991) Obstructive sleep apnea treatment: peripheral and central effects on plasma renin activity and aldosterone. Sleep 14:211–217PubMed
29.
Zurück zum Zitat Umlauf MG, Chasens ER (2003) Sleep disordered breathing and nocturnal polyuria: nocturia and enuresis. Sleep Med Rev 7:403–411CrossRefPubMed Umlauf MG, Chasens ER (2003) Sleep disordered breathing and nocturnal polyuria: nocturia and enuresis. Sleep Med Rev 7:403–411CrossRefPubMed
30.
Zurück zum Zitat Umlauf MG, Chasens ER, Greevy RA et al (2004) Obstructive sleep apnea, nocturia and polyuria in older adults. Sleep 27:139–144PubMed Umlauf MG, Chasens ER, Greevy RA et al (2004) Obstructive sleep apnea, nocturia and polyuria in older adults. Sleep 27:139–144PubMed
31.
Zurück zum Zitat Baruzzi A, Riva R, Cirignotta F et al (1991) Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome. Sleep 14:83–86PubMed Baruzzi A, Riva R, Cirignotta F et al (1991) Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome. Sleep 14:83–86PubMed
32.
Zurück zum Zitat Krieger J, Follenius M, Sforza E et al (1991) Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea. Clin Sci (Lond) 80:443–449 Krieger J, Follenius M, Sforza E et al (1991) Effects of treatment with nasal continuous positive airway pressure on atrial natriuretic peptide and arginine vasopressin release during sleep in patients with obstructive sleep apnoea. Clin Sci (Lond) 80:443–449
33.
Zurück zum Zitat Krieger J, Laks L, Wilcox I et al (1989) Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and during treatment with nasal continuous positive airway pressure. Clin Sci (Lond) 77:407–411 Krieger J, Laks L, Wilcox I et al (1989) Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and during treatment with nasal continuous positive airway pressure. Clin Sci (Lond) 77:407–411
34.
Zurück zum Zitat Lin CC, Tsan KW, Lin CY (1993) Plasma levels of atrial natriuretic factor in moderate to severe obstructive sleep apnea syndrome. Sleep 16:37–39PubMed Lin CC, Tsan KW, Lin CY (1993) Plasma levels of atrial natriuretic factor in moderate to severe obstructive sleep apnea syndrome. Sleep 16:37–39PubMed
35.
36.
Zurück zum Zitat Coy TV, Dimsdale JE, Ancoli-Israel S, Clausen J (1996) Sleep apnoea and sympathetic nervous system activity: a review. J Sleep Res 5:42–50CrossRefPubMed Coy TV, Dimsdale JE, Ancoli-Israel S, Clausen J (1996) Sleep apnoea and sympathetic nervous system activity: a review. J Sleep Res 5:42–50CrossRefPubMed
37.
Zurück zum Zitat Waradekar NV, Sinoway LI, Zwillich CW, Leuenberger UA (1996) Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med 153:1333–1338CrossRefPubMed Waradekar NV, Sinoway LI, Zwillich CW, Leuenberger UA (1996) Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med 153:1333–1338CrossRefPubMed
38.
Zurück zum Zitat Khoo MC, Kim TS, Berry RB (1999) Spectral indices of cardiac autonomic function in obstructive sleep apnea. Sleep 22:443–451PubMed Khoo MC, Kim TS, Berry RB (1999) Spectral indices of cardiac autonomic function in obstructive sleep apnea. Sleep 22:443–451PubMed
Metadaten
Titel
Anfängliche Gewichtszunahme bei kontinuierlicher Positivdruck-Therapie wegen obstruktiver Schlafapnoe
Anfängliche Gewichtszunahme bei CPAP-Therapie
verfasst von
R.E. Bourey, MD, FAASM
J.R. Bourey
N. Habbal
A. Balaa
Publikationsdatum
01.09.2010
Verlag
Springer Berlin Heidelberg
Erschienen in
Somnologie / Ausgabe 3/2010
Print ISSN: 1432-9123
Elektronische ISSN: 1439-054X
DOI
https://doi.org/10.1007/s11818-010-0483-8

Weitere Artikel der Ausgabe 3/2010

Somnologie 3/2010 Zur Ausgabe

Mitteilungen der DGSM

kjfjksöadjfasjldf

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.